These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7876649)
1. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals. Sandman L; Davidson M; Krugman S J Infect Dis; 1995 Mar; 171 Suppl 1():S50-2. PubMed ID: 7876649 [TBL] [Abstract][Full Text] [Related]
2. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals. Davidson M; Krugman S; Sandman LA Vaccine; 1992; 10 Suppl 1():S119-20. PubMed ID: 1335639 [TBL] [Abstract][Full Text] [Related]
3. Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine. Theilmann L; Kallinowski B; Gmelin K; Hofmann F; Scheiermann N; Wohland B; Stickl H; Maiwald H; Moriabadi FK; Bock HL Vaccine; 1992; 10 Suppl 1():S132-4. PubMed ID: 1335644 [TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children. Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience with an inactivated hepatitis A vaccine. Clemens R; Safary A; Hepburn A; Roche C; Stanbury WJ; André FE J Infect Dis; 1995 Mar; 171 Suppl 1():S44-9. PubMed ID: 7876648 [TBL] [Abstract][Full Text] [Related]
6. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379 [TBL] [Abstract][Full Text] [Related]
7. Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine: early immune response, persistence of antibody, and response to a third dose at 1 year. DeFraites RF; Feighner BH; Binn LN; Kanjarpane DD; Delem AD; MacArthy PO; Krauss MR; Krause DS; Moonsammy GI; Hoke CH J Infect Dis; 1995 Mar; 171 Suppl 1():S61-9. PubMed ID: 7876651 [TBL] [Abstract][Full Text] [Related]
8. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A]. Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633 [TBL] [Abstract][Full Text] [Related]
9. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters. Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children. Newcomer W; Rivin B; Reid R; Moulton LH; Wolff M; Croll J; Johnson C; Brown L; Nalin D; Santosham M Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954 [TBL] [Abstract][Full Text] [Related]
11. Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine. Hoke CH; Egan JE; Sjogren MH; Sanchez J; DeFraites RF; MacArthy PO; Binn LN; Rice R; Burke A; Hill J J Infect Dis; 1995 Mar; 171 Suppl 1():S53-60. PubMed ID: 7876650 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans. Guan R; Ng HS; Fock KM; Ho KY; Yap I; Kang JY; Chow WC; Chew CN; Ng C; Teo CJ Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):268-71. PubMed ID: 8629058 [TBL] [Abstract][Full Text] [Related]
13. Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. Van Damme P; Matheï C; Thoelen S; Meheus A; Safary A; André FE J Med Virol; 1994 Dec; 44(4):435-41. PubMed ID: 7897376 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of inactivated hepatitis A vaccine in children. Lee SD; Lo KJ; Chan CY; Yu MY; Wang YJ; Safary A Gastroenterology; 1993 Apr; 104(4):1129-32. PubMed ID: 8462802 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine. Dagan R; Greenberg D; Goldenbertg-Gehtman P; Vidor E; Briantais P; Pinsk V; Athias O; Dumas R Vaccine; 1999 Apr; 17(15-16):1919-25. PubMed ID: 10217590 [TBL] [Abstract][Full Text] [Related]
16. Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A. Ellerbeck EF; Lewis JA; Nalin D; Gershman K; Miller WJ; Armstrong ME; Davide JP; Rhoad AE; McGuire B; Calandra G Vaccine; 1992; 10(10):668-72. PubMed ID: 1523877 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later. Briem H; Safary A J Med Virol; 1994 Dec; 44(4):443-5. PubMed ID: 7897378 [TBL] [Abstract][Full Text] [Related]
19. Effect of hepatitis A vaccination schedules on immune response. Tilzey AJ; Palmer SJ; Barrow S; Perry KR; Tyrell H; Safary A; Banatvala JE Vaccine; 1992; 10 Suppl 1():S121-3. PubMed ID: 1335640 [TBL] [Abstract][Full Text] [Related]
20. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine. Goubau P; Van Gerven V; Safary A; Delem A; Knops J; D'Hondt E; André FE; Desmyter J Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]